While the Company repeatedly claimed that scientific research did not support a correlation between Zantac and cancer ... What Is The Lawsuit About? The complaint filed in this class action ...

While the Company repeatedly claimed that scientific research did not support a correlation between Zantac and cancer, the Deutsche Bank report ... thereby injuring investors further. What Is The ...

who did not know that GSK had for decades concealed an internal study that implicated GSK's liability to Zantac users. When the true details entered the market, the lawsuit claims that investors ...

Cruz announces that a class action lawsuit has been filed on behalf ... research did not support a correlation between Zantac and cancer, the Deutsche Bank report stated that the total liability ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

LEONARDO MUNOZ/AFP via Getty Images. © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy ...

According to the complaint, in September and October 2019, GSK suspended its distribution of Zantac ... of cancer-stricken patients filed personal injury and product liability lawsuits against ...

GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a ... risk for any type of cancer”. Counsel for the plaintiffs in the lawsuits are claiming that ...

Despite a mixed fourth-quarter revenue performance, British pharmaceutical giant GSK remains optimistic about its long-term growth prospects, particularly with its ambitious revenue target for 2031.